DK1126853T3 - Kontrolleret levering af antidepressine midler - Google Patents

Kontrolleret levering af antidepressine midler

Info

Publication number
DK1126853T3
DK1126853T3 DK99971322T DK99971322T DK1126853T3 DK 1126853 T3 DK1126853 T3 DK 1126853T3 DK 99971322 T DK99971322 T DK 99971322T DK 99971322 T DK99971322 T DK 99971322T DK 1126853 T3 DK1126853 T3 DK 1126853T3
Authority
DK
Denmark
Prior art keywords
antidepressants
controlled delivery
triazolones
exemplified
methods
Prior art date
Application number
DK99971322T
Other languages
English (en)
Inventor
Atul Ayer
Evangeline G Cruz
Adam Zhong
Padmanabh Bhatt
Noymi Yam
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK1126853T3 publication Critical patent/DK1126853T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99971322T 1998-11-02 1999-10-26 Kontrolleret levering af antidepressine midler DK1126853T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10675898P 1998-11-02 1998-11-02
US10667798P 1998-11-02 1998-11-02

Publications (1)

Publication Number Publication Date
DK1126853T3 true DK1126853T3 (da) 2006-08-14

Family

ID=26803899

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99971322T DK1126853T3 (da) 1998-11-02 1999-10-26 Kontrolleret levering af antidepressine midler

Country Status (12)

Country Link
EP (1) EP1126853B1 (da)
JP (1) JP4711510B2 (da)
KR (2) KR100734193B1 (da)
AT (1) ATE323493T1 (da)
AU (1) AU1230800A (da)
CA (1) CA2349719C (da)
CY (1) CY1105463T1 (da)
DE (1) DE69930952T2 (da)
DK (1) DK1126853T3 (da)
ES (1) ES2260962T3 (da)
PT (1) PT1126853E (da)
WO (1) WO2000025790A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ570198A (en) * 2002-07-29 2010-01-29 Alza Corp Methods and dosage forms for controlled delivery of paliperidone or risperidone
CA2494233A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
CA2540308C (en) 2003-09-26 2013-08-06 Alza Corporation Drug coating providing high drug loading and methods for providing the same
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
CN101703488B (zh) * 2008-12-16 2013-02-20 北京科信必成医药科技发展有限公司 具有润滑层结构的双层渗透泵控释片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082668A (en) * 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
JP4015184B2 (ja) * 1993-08-31 2007-11-28 アルザ コーポレイション 疎水性剤を含有するディスペンサー
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
ES2208870T3 (es) * 1996-02-15 2004-06-16 Janssen Pharmaceutica N.V. Uso de antagonistas del receptor 5ht4 para resolver los efectos gastrointestinales de los inhibidores de la reabsorcion de serotonina.
AU3290397A (en) * 1996-06-10 1998-01-07 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form

Also Published As

Publication number Publication date
JP4711510B2 (ja) 2011-06-29
CA2349719C (en) 2009-06-02
HK1038515A1 (en) 2002-03-22
EP1126853A1 (en) 2001-08-29
CY1105463T1 (el) 2010-04-28
EP1126853B1 (en) 2006-04-19
CA2349719A1 (en) 2000-05-11
KR20010075677A (ko) 2001-08-09
AU1230800A (en) 2000-05-22
ES2260962T3 (es) 2006-11-01
DE69930952T2 (de) 2006-08-31
KR100734193B1 (ko) 2007-07-02
PT1126853E (pt) 2006-07-31
DE69930952D1 (de) 2006-05-24
WO2000025790A1 (en) 2000-05-11
KR20070040421A (ko) 2007-04-16
ATE323493T1 (de) 2006-05-15
JP2002528505A (ja) 2002-09-03

Similar Documents

Publication Publication Date Title
EE200100293A (et) Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
BR9703302A (pt) Aparelho e método para a geração e uso de ìons férricos
DK1066269T3 (da) Trisubstituerede 1,3,5-triazinderivater til behandling af HIV-infektioner
IL147618A0 (en) Method for treating chronic pain using mek inhibitors
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
MXPA03007140A (es) Derivados de carbolina.
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
GB2387696A (en) Real-time odds-based gaming
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
YU5800A (sh) Univerzalno primenljiva krvna plazma
DK1033990T3 (da) 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud
ATE248822T1 (de) Partikel mit kontrollierter freisetzungsrate
DE60112671D1 (de) Gebogener, elastischer Zahnregulierungsring
DK1235579T3 (da) Farmaceutiske præparater med indhold af trimegeston
DK1126853T3 (da) Kontrolleret levering af antidepressine midler
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
TR199901017A2 (xx) B�cek ilac� terkibi.
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.
DK1052995T3 (da) Farmaceutisk præparat til nasal indgivelse af thiocolchicosid